| Literature DB >> 32343340 |
Alexander C M Greven1, Christopher W Rich1, James G Malcolm1, David P Bray1, Gerald E Rodts1, Daniel Refai1, Matthew F Gary1.
Abstract
Entities:
Year: 2020 PMID: 32343340 PMCID: PMC7197572 DOI: 10.1093/neuros/nyaa165
Source DB: PubMed Journal: Neurosurgery ISSN: 0148-396X Impact factor: 4.654
Telemedicine Regulatory Requirements[7,8]
| Pre-COVID-19 | During COVID-19 |
|---|---|
|
| “Originating site” requirement was waived so that patients can receive services from their homes |
|
| Patients are now able to use personal phones and tablets to receive services; everyday communication technologies like FaceTime and Skype are acceptable |
|
| Wide range of services are now available; new patients are now eligible to receive telemedicine services |
|
| Clinicians are now able to prescribe schedule II to V controlled substances to patients seen using telemedicine communication |
Virtual Visits for Providers Who Can Bill Evaluation and Management Services During COVID-19 Emergency (eg, Physicians, Nurse Practitioners, Physician Assistants, Nurse-Midwives, Clinical Nurse Specialists, Certified Registered Nurse Anesthetists)
| Method of communication | What is the service? | CPT/HCPCS code | Patient relationship with provider | Documentation requirements | Suggested attestations | Payors |
|---|---|---|---|---|---|---|
| Zoom, FaceTime, Univago, American Well | A |
| New or established | Documentation should mirror an in-person office visit | This is a telehealth visit that was performed with the originating site at PATIENT LOCATION and the distant site at PROVIDER LOCATION I would evaluate the patient and recommend diagnostics and treatments based on my assessment Our sessions are not being recorded and that personal health information is protected Our team would provide follow up care in person if/when the patient needs it | All payors G (Medicare only) |
| Telephone only | A |
| Established | Documentation should include a summary of the telephone discussion and the total amount of time spent in medical discussion. | This is a telephone visit that was performed on DATE OF SERVICE. Verbal consent to participate in the telephone visit was obtained. This particular visit occurred during the 2020 COVID-19 outbreakI discussed with the patient the nature of our telephone call, that:
I would evaluate the patient and recommend diagnostics and treatments based on my assessment Our calls are not being recorded and that personal health information is protected Our team would provide follow up care in person if/when the patient needs it | Medicaid, Blue Cross; other payors may expand their policy during the COVID emergency |
| EMR exchange (portal) | An |
| Established | Documentation should include how the patient was contacted and how much time was spent on each encounter | This is an online digital evaluation and management service that was initiated from the patient on the date of service above via EMORY PATIENT PORTAL. | All payors G (Medicare only) |
Allowed during COVID emergency.